U.S., Feb. 1 -- ClinicalTrials.gov registry received information related to the study (NCT06236802) titled 'ProVIDE II Bridging Study' on Jan. 24.

Brief Summary: The purpose of the ProVIDE II Bridging Study is to evaluate the performance of the Generation II delivery system when deploying the ProVee expander in subjects with symptomatic urinary obstruction secondary to BPH.

Study Type: Interventional

Condition: BPH With Symptomatic Lower Urinary Tract Symptoms

Intervention: Device: ProVee device

ProVee Expander is placed in prostatic urethra to relieve obstruction due to BPH.

Other Names: * ProVee Expander

* ProVee

Recruitment Status: Not Yet Recruiting

Published by HT Digital Content Services with permission from Health Daily Dige...